eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
10.01
0.00 (0.00%)
Aug 7, 2025, 4:00 PM - Market closed

Company Description

eXoZymes, Inc. operates as a development stage biotechnology company.

The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing.

The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025.

eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

eXoZymes, Inc.
eXoZymes logo
CountryUnited States
Founded2014
IndustryBiotechnology
SectorHealthcare
Employees31
CEOMichael Heltzen

Contact Details

Address:
750 Royal Oaks Drive, Suite 106
Monrovia, California 91016
United States
Phone626 415 1488
Websiteexozymes.com

Stock Details

Ticker SymbolEXOZ
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0002010788
ISIN NumberUS4618741098

Key Executives

NamePosition
Michael HeltzenPresident and Chief Executive Officer
Dr. Tyler Korman Ph.D.Co-Founder and Vice President of Research
Dr. Paul Opgenorth Ph.D.Co-Founder and Vice President of Development
Fouad NawazVice President of Finance
James U. Bowie Ph.D.Founder and Independent Director
Lasse H. GorlitzVice President of Communications
Michael BurnsExecutive Vice President of Energy Transition
Dr. Zachary Karl Ph.D.Vice President and Head of Business Development
Damien A. PerrimanChief Commercial Officer